Signs of Fatigue<br />By Rev Shark<br />RealMoney.com Contributor<br />10/28/2009 7:59 AM EDT<br /><br /> Because things are the way they are, things will not stay the way they are.<br /> -- Bertolt Brecht<br /><br />The secret to successful trading it to ride market momentum as far as you can and then quickly move out of the way once it ends. That is much harder than it sounds, because the market seldom acts in a way that feels rational. Momentum almost always lasts far longer than you think it will; when it does end, it can do so in a very abrupt manner with little warning. The problem we always have to struggle with is trying to distinguish a routine pullback from a major change in trend.<br /><br />The current market has been particularly frustrating for those who have been trying to guess when the momentum might end. No reasonable person could have anticipated that the market would rally as much has it has and in the manner it has since the March low. After a once-in-a-generation collapse, we experienced a straight-up recovery of remarkable magnitude and velocity while the economy was still showing only minor signs of recovery. How could we blame folks for being very skeptical about embracing this market after what we have gone through?<br /><br />Questioning whether the market move was justified on a fundamental basis would almost assure that you would be standing on the sidelines for much of the move. However, it has just kept going and going -- this has been one of the most unloved and disliked rallies that I have ever experienced.<br /><br />In retrospect, it is very obvious now that a flood of liquidity caused by bailouts and stimulus drove this market. Money was being printed at a record pace to save the economy, and it had nowhere to go but into stocks. As folks realized what was happening, they become frustrated about being left out and they helped chase the market even higher as they bought every little dip or pullback.<br /><br />Over the past couple of weeks, the market has started to show some signs of fatigue. The biggest change has been that good news of earnings reports has failed to drive stocks higher. The vast majority of earnings reports beat expectations, but the market has been unable to make any headway. This is the first time since March that the market has shown indications that it may have gotten ahead of itself.<br /><br />Other signs of a mood change are always evident. We have a number of intraday reversals to the downside, we have closed weak on a number of days and the economic data is being viewed in a harsher light. In the early days of this rally, all that mattered from the economic numbers was that they be a little "less bad." Now the standards are a bit higher, and we aren't living up to them.<br /><br />So is this the long-awaited market correction that so many have been looking for since the March low? It certainly has the feel of something more severe this time, but this market has not been kind to anyone who has been too skeptical of its strength. We may once again immediately recover and go straight back up, but the current poor action requires that we increase our caution and assume that maybe there is more downside to come.<br /><br />On the way up, the smart move was to defer to the strong price action even if you had doubts about the fundamentals of this market. The trend was the key. Now that the trend is showing signs of ending, we have to make adjustments to respect that fact. If the market does find its footing and quickly turn back up, we may be standing on the sidelines feeling frustrated, but the most important thing is to see what is happening in front of you and embrace it rather than fight it.<br /><br />We have more weak action in the early going this morning, but the market is oversold and I'm looking for a more aggressive bounce attempt today. Whether it lasts for long will be the real measure of market character, but we will most likely give it a try. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: QTM +11.7%, WSII +11.0%, CQB +8.1%, CBI +8.0%, NATI +7.2%, RFMD +7.0%, HRS +5.4%, PEET +5.3% (also upgraded to Buy at Stifel Nicolaus), PNRA +5.3%, WBC +5.0% (light volume), IP +4.9%, IDTI +4.2%, CENX +3.6%, PMTC +3.6%, NMR +3.2%, DWA +3.2% (also upgraded to Outperform from Market at BMO Capital Markets), Q +2.9%, CAVM +2.6% (light volume), DT +2.5% (light volume), V +1.9%, MCK +1.7%, CEPH +1.4%... Other news: NDAQ (light volume; introduced The NASDAQ OMX Industry Leaders Index), ELN +4.5% (Elan and Biogen announce that positive clinical data on Tysabri, it significantly reduces hospitalization rates in patients with Crohn's Disease), NFLX +1.7% (Cramer makes positive comments on MadMoney), DAL +2.0% and CAL +1.1% (still checking)... Analyst comments: CYCC +15.8% (initiated with Buy at Merriman), PNNT +3.6% (upgraded to Outperform at Keefe Bruyette), WAT +2.6% (upgraded to Buy from Hold at Deutsche Bank), EW +2.4% (upgraded to Buy from Neutral at Goldman-Reuters), TGT +2.4% (upgraded to Buy at Citigroup), WYNN +1.2% (upgraded to Outperform at Oppenheimer).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: KSP -17.6%, APOL -17.4% (also announces Securities and Exchange Commission informal inquiry; downgraded by multiple analysts), PSYS -15.1% (also downgraded to Market Perform from Strong Buy at Raymond James), ILMN -14.8%, VCLK -14.0% (also downgraded to Hold from Buy at ThinkEquity), ID -7.8%, SAP -7.4%, BWLD -6.4%, APT -5.8%, ABAX -5.4%, PUK -4.6%, WTS -4.4%, MRCY -3.9% (light volume), ETFC -3.2%... Select education related names showing weakness in sympathy with APOL: COCO -5.8%, LOPE -5.7%, CECO -4.6%, STRA -4.3%, CPLA -1.3%... Select financial related names trading lower: AIB -18.4% and IRE -16.3% (Irish bank shares sink as rescue timing worries weigh - Reuters.com), AXA -3.6%, AEG -3.2%, UBS -2.6%, AIG -2.4%, CS -1.5%, STD -1.0%, BBV -1.0%... Select metals/mining names showing weakness: RTP -3.5% (Rio Tinto completes second tranche of its investment in Ivanhoe Mines), GOLD -3.1%, BBL -2.6%, BHP -2.3%... Other news: SWSI -10.4% (announces it has commenced a 6 mln share common stock offering pursuant to an effective shelf registration; downgraded to Underperform from Market Perform at BMO Capital Markets ), CLDA -7.6% (announces public offering of common stock), GRMN -5.0% (TomTom's net declines 47% - WSJ), ABB -3.2% (still checking), AMD -2.9% (Ex-Chief of AMD is linked to Galleon - WSJ), KHD -2.5% (adjusts contracts at risk; backlog now at $614.8 million), AZN -1.0% (AstraZeneca pulls Zactima cancer treatment drug applications - DJ)... Analyst comments: APEI -6.7% (downgraded to Neutral at Sterne Agee), MELA -4.3% (downgraded to Hold at Roth), SNDK -2.6% (downgraded to Neutral from Buy at Goldman-Reuters), NVDA -1.9% (downgraded to Hold at Roth), MRVL -1.0% (downgraded to Hold at Roth).